NCT01124422 - Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease | Biotech Hunter

Enrollment

255

Participants

Timeline

Start Date

July 19, 2010

Primary Completion Date

May 1, 2011

Study Completion Date

May 2, 2011

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

fluticasone propionate/salmeterol inhalation powder DISKUS 250/50

Experimental comparator consisting of inhaled corticosteroid plus long-acting beta agonist combination also known as ADVAIR DISKUS

DRUG

tiotropium bromide inhalation powder HandiHaler

Open-label drug also known as Spiriva HandiHaler

Trial Locations (27)

12205

GSK Investigational Site, Albany

23229

GSK Investigational Site, Richmond

29303

GSK Investigational Site, Spartanburg

29340

GSK Investigational Site, Gaffney

29379

GSK Investigational Site, Union

29615

GSK Investigational Site, Greenville

29640

GSK Investigational Site, Easley

35294

GSK Investigational Site, Birmingham

63301

GSK Investigational Site, Saint Charles

68131

GSK Investigational Site, Omaha

77030

GSK Investigational Site, Houston

77380

GSK Investigational Site, The Woodlands

77598

GSK Investigational Site, Webster

80528

GSK Investigational Site, Fort Collins

85006

GSK Investigational Site, Phoenix

90505

GSK Investigational Site, Torrance

06105

GSK Investigational Site, Hartford

03756

GSK Investigational Site, Lebanon

T2N 4Z6

GSK Investigational Site, Calgary

V5Z 1M9

GSK Investigational Site, Vancouver

B3H 3A7

GSK Investigational Site, Halifax

L9H 7S4

GSK Investigational Site, Hamilton

K7L 2V7

GSK Investigational Site, Kingston

M5T 3A9

GSK Investigational Site, Toronto

H4J 1C5

GSK Investigational Site, Montreal

G1V 4G5

GSK Investigational Site, Québec

S7N 0W8

GSK Investigational Site, Saskatoon